Researchers turn cancer resistance mutations into targets for new immunotherapies

One of the most challenging moments in cancer treatment comes when a therapy stops working. In many metastatic cancers, drugs that are initially effective lose their potency over time, as malignant cells acquire mutations that enable them to survive and spread.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup